Barr Pharmaceuticals is Pharmaceuticals in United States that focus on product portfolio business. Founded in 1970. They cover business area such as manufacturer, generic prescription pharmaceutical product, solid oral dosage form, injectable, cream and ointment product, SEASONIQUE, an extend-cycle oral contraceptive, PLAN BTM, the-counter, an iuc contraceptive product, Mircette, ENJUVIA, a line, hormone therapy product.
1970
( 54 years old in 2024 )
Product Portfolio
-
225 Summit Avenue
Montvale, NJ 07645
United States
Private
manufacturergeneric prescription pharmaceutical productsolid oral dosage forminjectablecream and ointment productSEASONIQUEan extend-cycle oral contraceptivePLAN BTMthe-counteran iuc contraceptive productMircetteENJUVIAa linehormone therapy product
* We use standard office opening hours in near Barr Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Barr Pharmaceuticals is Pharmaceuticals business from United States that founded in 1970 (54 years old in 2024), Barr Pharmaceuticals business is focusing on Product Portfolio.
Barr Pharmaceuticals headquarter office and corporate office address is located in 225 Summit Avenue Montvale, NJ 07645 United States.
Barr Pharmaceuticals was founded in United States.
In 2024, Barr Pharmaceuticals is currently focus on product portfolio sector.
Above is snippet of Google Trends for "product portfolio" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Barr Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
